NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Software
Agency / Source: APTEAN

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Aptean and CAS Expand Collaboration with Biosequence Chemical Modifications Solution - New Capabilities Streamline Life Science Patent Search - CAS.org / Aptean.com
Aptean and CAS Expand Collaboration with Biosequence Chemical Modifications Solution

 

NewswireTODAY - /newswire/ - Alpharetta, GA, United States, 2025/12/19 - New Capabilities Streamline Life Science Patent Search - CAS.org / Aptean.com. NASDAQ: TRMB

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Software Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Aptean, a global leader in AI-powered enterprise software for industrial sectors, and CAS, a division of the American Chemical Society specializing in scientific knowledge management, today announce an expanded collaboration designed to help biotech intellectual property researchers assess patentability with greater speed and precision.

The collaborators’ combined expertise delivers a new Chemical Modifications module featuring Aptean GenomeQuest's search experience integrated with CAS biological sequence data. Users can detect a wide variety of chemical modifications by combining exact positions, floating patterns, and filters on the number of modification occurrences within a sequence. The module offers a comprehensive and flexible approach that covers the majority of relevant use cases, making it easier to capture and review pertinent patents across diverse biological modification patterns.

“By combining our intuitive IP search platform with CAS comprehensive, high-quality biosequence data, we empower researchers to confidently assess intellectual property and gain insights tied to chemically modified sequences, an essential step in advancing drug development and therapeutic innovation,” said Dr. Henk Heus, AVP of Product and Technology at Aptean.

This innovative new offering expands the long-standing partnership between CAS and Aptean, now allowing customers to procure both the Chemical Modification module and CAS Biosequences directly through Aptean GenomeQuest.

Dr. Michael Dennis, CAS Chief Science Officer, noted that “Expanding our collaboration with Aptean through the Chemical Modification module presents an exciting opportunity to further our mission of accelerating life sciences innovation globally by enhancing discoverability of critical biosequence data via the GenomeQuest platform.”

Availability will follow a phased rollout with beta access starting early January 2026, and a full launch is expected by the end of Q1 2026.

About Aptean

Aptean (aptean.com) is an AI platform leader that combines Vertical AI with an extensive range of industry-specific applications from ERP to supply chain solutions such as asset management, transportation management, warehouse management, and more to help businesses become more agile, productive, and profitable. With a focus on practical innovation and a passion for customer success, Aptean helps companies in manufacturing, distribution, apparel, food and beverage, life sciences, and many other sectors to redefine what’s possible.

About CAS

CAS (cas.org) connects the world's scientific knowledge to accelerate breakthroughs that improve lives. We empower global innovators to efficiently navigate today’s complex data landscape and make confident decisions in each phase of the innovation journey. As a specialist in scientific knowledge management, our team builds the largest authoritative collection of human-curated scientific data in the world and provides essential information solutions, services, and expertise. Scientists, patent professionals, and business leaders across industries rely on CAS to help them uncover opportunities, mitigate risks, and unlock shared knowledge so they can get from inspiration to innovation faster. CAS is a division of the American Chemical Society.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Software Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: APTEAN

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
Software Warnings - IMPORTANT:
Always be aware/cautious about what you download on your computer/mobile! PURCHASE SOFTWARE related keywords / Banner Ads. Click HERE for details!
.

 
  Your Banner Ad showing on ALL
Software articles,
CATCH Visitors via Your Competitors Announcements!


Aptean and CAS Expand Collaboration with Biosequence Chemical Modifications Solution

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
CAS Biosequence | Aptean
Contact: Geraldine O'Neill - Aptean.com 
geraldine.oneill[.]aptean.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any APTEAN securities in any jurisdiction including any other companies listed or named in this release.

Software via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From APTEAN / Company Profile


Read Software Most Recent Related Newswires:

Absa Bank Modernizes Credit Risk Management Reporting with SAS
Thales Launches Imperva for AWS to Help Organizations Protect Applications and APIs
Siemens Launches SIMATIC AX WinCC Unified Elements
Oracle to Make Gemini Models Available to Thousands of Enterprise Applications Customers
Nissin Foods Teams Up with Highspring and Blue Yonder to Adopt AI-driven Supply Chain Planning for Faster, Smarter Decisions
Apexon Signs Strategic Collaboration Agreement with AWS to Deliver Agentic AI Solutions for Healthcare and Life Sciences
Siemens to Acquire Defacto Technologies to Complement its EDA Portfolio with Automated SoC Design Creation
Siemens Partners with Ministry of Energy and Infrastructure Inaugurates Emirates Monitoring Center
Siemens and Cloudberry VC Collaborate to Accelerate European Deep-tech Innovation
SAS Recognized on rhe Prestigious 2026 MES Midmarket 100 List
Oracle Joins IMSA Labs as Founding Partner to Accelerate AI and Motorsport Innovation
SAS Aces Chartis’ 2026 Fraud Platform Evaluation, Best-in-class in Every Category
Quest Software Strengthens Identity Security and Resilience for the AI Era, Achieving FedRAMP® High Authorized Certification for Identity Defense and
SAS Marks 50 Years of Trusted Innovation and Global Impact
Oracle Financial Services Named Leader Across Four Categories in Chartis Credit Lending Operations Report

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit BizJobs.com

Visit  Limelon Advertising, Co.





 
  ©2005-2026 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)